Subscribe to RSS
Investigation of High-Risk ST131 Clone in Extended Spectrum β-Lactamase–Producing Escherichia coli Isolates in ChildrenFunding None.
Objective Antimicrobial resistance poses a serious threat to children's health. In recent years, high-risk Escherichia coli ST131 has become an important target for global surveillance studies. The E.coli ST131 clone is associated with extended spectrum β-lactamase (ESBL) production, as well as multidrug resistance and treatment failure. Studies on this clone in the pediatric age group are limited. We aim to investigate the rate of high-risk E. coli ST131 clone in ESBL-positive E. coli isolates obtained from pediatric patients.
Methods A total of 292 ESBL-positive E. coli isolates from clinical samples of pediatric patients was included in the study. MALDI-TOF MS system was used for bacterial identification. Susceptibility tests were performed using BD Phoenix automated system. ST131 detection was done by MALDI-TOF-MS. Fisher's exact test was used to compare the groups (significance <0.05).
Results A total of 292 isolates was analyzed. The high-risk ST131 clone was detected in 117 (40%) of the 292 ESBL-positive isolates. ST131 rates were found to be significantly higher in children under the age of 5 years compared with children over the age of 5 years (49.3 vs. 31.1%, p = 0.0019). Ciprofloxacin resistance was higher in ST131 isolates (45.6 vs. 31.7%; p < 0.05).
Conclusion The rate of the ST131 clone was found to be high in the pediatric population. The significantly high rate of resistance to ciprofloxacin, which is not commonly used in the pediatric population, in ST131 isolates reveals the importance of the spread of high-risk clones for the development of resistance.
This study was approved by the University of Health Sciences, Sisli Hamidiye Etfal, Training and Research Hospital ethics committee, resolution 2945.
Received: 09 November 2020
Accepted: 29 March 2021
15 June 2021 (online)
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Brinkac L, Voorhies A, Gomez A, Nelson KE. The threat of antimicrobial resistance on the human microbiome. Microb Ecol 2017; 74 (04) 1001-1008
- 2 Laxminarayan R, Matsoso P, Pant S. et al. Access to effective antimicrobials: a worldwide challenge. Lancet 2016; 387 (10014): 168-175
- 3 Birgy A, Levy C, Bidet P. et al. ESBL-producing Escherichia coli ST131 versus non-ST131: evolution and risk factors of carriage among French children in the community between 2010 and 2015. J Antimicrob Chemother 2016; 71 (10) 2949-2956
- 4 Liu CM, Stegger M, Aziz M. et al. Escherichia coli ST131–H22 as a foodborne uropathogen. MBio 2018; 9 (04) e00470-18
- 5 Cizmeci Z, Otlu B, Aktas E, Ördekci S, Acikgöz Ö, Gülec N. [Investigation of high-risk ST131 clone in ESBL-producing Escherichia coli isolates isolated from urine and non-urinary clinical specimens with MALDI-TOF MS and real time PCR] (in Turkish). Mikrobiyol Bul 2018; 52 (01) 13-22
- 6 Huang IF, Lee WY, Wang JL. et al. Fecal carriage of multidrug-resistant Escherichia coli by community children in southern Taiwan. BMC Gastroenterol 2018; 18 (01) 86
- 7 Miles-Jay A, Weissman SJ, Adler AL. et al. Epidemiology and antimicrobial resistance characteristics of the ST131–H30 subclone among extraintestinal Escherichia coli collected from US children. Clin Infect Dis 2017; 66 (03) 411-419
- 8 Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother 2014; 58 (09) 4997-5004
- 9 Aktas E, Otlu B, Erdemir D, Ekici H, Bulut E. A first insight into Escherichia coli ST131 high-risk clone among extended-spectrum beta-lactamase-producing urine isolates in Istanbul with the use of matrix-assisted laser desorption/ionization time-of-flight mass-spectrometry and real-time PCR. Microb Drug Resist 2017; 23 (08) 1032-1036
- 10 Lafolie J, Sauget M, Cabrolier N, Hocquet D, Bertrand X. Detection of Escherichia coli sequence type 131 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: implications for infection control policies?. J Hosp Infect 2015; 90 (03) 208-212
- 11 Mathers AJ, Peirano G, Pitout JDD. Escherichia coli ST131: the quintessential example of an international multiresistant high-risk clone. Adv Appl Microbiol 2015; 90: 109-154
- 12 Mathers AJ, Peirano G, Pitout JDD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant enterobacteriaceae. Clin Microbiol Rev 2015; 28 (03) 565-591
- 13 Matsumura Y, Yamamoto M, Nagao M. et al. Detection of extended-spectrum-β-lactamase-producing Escherichia coli ST131 and ST405 clonal groups by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2014; 52 (04) 1034-1040
- 14 Chung HC, Lai CH, Lin JN. et al. Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother 2012; 56 (02) 618-622
- 15 EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. 0 (2017–07–11). Accessed April 19, 2021 at; https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance_mechanisms/EUCAST_detection_of_resistance_mechanisms_170711.pdf
- 16 Jafari A, Falahatkar S, Delpasand K, Sabati H, Sedigh Ebrahim-Saraie H. Emergence of Escherichia coli ST131 causing urinary tract infection in Western Asia: a systematic review and meta-analysis. Microb Drug Resist 2020; 26 (11) 1357-1364
- 17 Can F, Azap OK, Seref C, Ispir P, Arslan H, Ergonul O. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections. Clin Infect Dis 2015; 60 (04) 523-527
- 18 Kına N. Investigation of high-risk ST131 clone in clinical Escherichia coli isolates. Clinical Microbiology laboratory thesis. 2019. . Available at: https://tez.yok.gov.tr/UlusalTezMerkezi/TezGoster?key=Mir2lXQK1dkmQ9Ige3PZbo3FcrJHletESTF0xtDCIZCyl2pNqX_KloRja747TMao
- 19 Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, Livermore DM. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob Agents Chemother 2009; 53 (10) 4472-4482
- 20 Madigan T, Johnson JR, Clabots C. et al. Extensive household outbreak of urinary tract infection and intestinal colonization due to extended-spectrum β-lactamase-producing Escherichia coli sequence type 131. Clin Infect Dis 2015; 61 (01) e5-e12
- 21 Peirano G, Bradford PA, Kazmierczak KM. et al. Global incidence of carbapenemase-producing Escherichia coli ST131. Emerg Infect Dis 2014; 20 (11) 1928-1931
- 22 Blanc V, Leflon-Guibout V, Blanco J. et al. Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J Antimicrob Chemother 2014; 69 (05) 1231-1237
- 23 Johnson JR, Davis G, Clabots C. et al. Household clustering of Escherichia coli sequence type 131 clinical and fecal isolates according to whole genome sequence analysis. Open Forum Infect Dis 2016; 3 (03) ofw129